Immunotherapy and GIST
This webinar provided an overview of immunotherapy with some examples of studies exploring single agent versus combination of therapy in GIST.
This webinar provided an overview of immunotherapy with some examples of studies exploring single agent versus combination of therapy in GIST.
Dr. Breelyn Wilky answering questions on a panel of GIST experts at Life Fest Miami, 2018. Colorado, Clinical Trials & Immunotherapy Dr. Wilky, Director of Sarcoma Translational Research at the University of [...]
A story about a cancer survivor recently appeared in the Washington Post: “This is not the end; Using immunotherapy and a genetic glitch to give cancer patients hope”. The story is about a young [...]
The Life Raft Group is pleased to announce the release of the tenth issue of The GIST Cancer Journal, the official journal of the Life Raft Group. The journal is intended to serve as [...]
The Life Raft Group is pleased to announce the release of the eighth issue of The GIST Cancer Journal, the official journal of the Life Raft Group and the first academic journal devoted solely [...]
Immunotherapy is a promising area in cancer research and in emerging treatments. Several new studies highlight the role that gut microbes may play in the efficacy of immunotherapy treatments.In a recent article in the Atlantic, [...]
Two recent articles summarize the promise that immunotherapy provides for the future of cancer treatment. Immunotherapy refers to treatments that aid your own immune system in fighting cancer cells. The first, from U.S. News [...]
Advanced Melanoma patients are now able to take a powerful new immuno-cology drug from Merck called Keytruda.
The future of cancer treatment relies on patient enrollment in clinical trials. In a recent Chicago Tribune article, a patient story is highlighted to illustrate the important role clinical trials play in cancer treatment, not only in [...]
A recent article from Cancer Research UK discusses immunotherapy, and the attention its role in the future of cancer treatment may play. In response to the interest in immunotherapy at the 50th Annual Meeting of [...]